Microbial natural products : a past with a future
New concepts and approaches to biodiversity
Nature products drug discovery at the National Cancer Institute : past achievements and new directions for the new millennium
Secondary metabolites as a vital source of animal health products
The relationship between natural products and synthetic chemistry in the discovery process
Natural products vs. combinatorials : a case study
Mushrooms, microbes and medicines
Signal transduction inhibitors from microorganisms
Novel inhibitors of lipoprotein associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579
Marine organisms as a source of novel lead structures for drug development
The anticancer dolastatins as cyanobacterial metabolites
A Cu² selective marine metabolite
Water soluble bioactive alkaloids
"Lessons from nature" : can ecology provide new leads in the search for novel bioactive chemicals from tropical rainforests?
Brazilian biodiversity : a source of phytomedicines, natural drugs and leads for the pharmaceutical and agrochemical industries
A modern perspective to the traditional use of plants in the highlands of Scotland
In vivo and in vitro biosynthetic studies : Understanding and exploiting natural pathways
Fused ring aromatic polyketides are formed by different cyclisation pathways in fungi and streptomycetes
The strobilurin fungicides : from mushroom to molecule to market
A synthesis of (+)prelog-Djerassi lactonic acid
N-([alpha]-aminoacyl)-5'-O-sulfamoyladenosines : natural product based inhibitors of amino acyl tRNA synthetases.